health care system in belgium how belgian patients can save 1 billion euro / year and the health...
TRANSCRIPT
Health care system in Belgium
How Belgian patients can save 1 billion euro / year and the health insurance system 1,6 billion / year …
Belgium
Statistical information
30,528 sq km about 10,4 million inhabitants three official languages (Dutch, French and
German) life expectancy: 78,29 years average of 1,62 born children / woman. USD 33,000 / capita GDP 8,7 % of this GDP: spent on health expenses 2.269 USD per capita / year: spent for health
of which 71,2 per cent are public expenses.
Basic principles of the health care system A liberal view of medicine.
Most health care providers are self-employed, receive payment for each service provided and enjoy diagnostic and therapeutic freedom.
System of compulsory health insurance system (RIZIV), integrated in the Social Security System and financed predominantly through salary deductions. More than 99% of the population is covered by compulsory health insurance at the present time.
The freedom to choose both the health care provider and the (private or public) health care establishment, so also free access to specialist doctors.
Reimbursement conditions (1)
The subscription to one of the existing health funds is compulsory, but the choice among them is free. ANMC, National Alliance of Christian Mutualities is by far the largest with 45% of the population
As a general rule, patients pay the total cost of services and then get reimbursed by their Mutual health fund on the basis of a contractually determined amount.
The difference between the total cost and the reimbursement is a personal contribution.
Exception to this rule: third-part payment, mainly for hospitalisation costs, pharmaceuticals and individuals living in a particular social and financial insecurity
Reimbursement conditions (2)
Supplementary insurance policies: voluntaryoffered by Mutual health funds (non
profit) and private companies (profit) Essentially co-payments by patients
and additional charges private hospital room, rest and care homes…
Public health system in danger
Budget of RIZIV: 15,3 billion euroRise of 4% / year
Reimbursement of medicines: 2,7 billion euro: Rise of 7,8% / year: expenses
increasing twice as fast as the total cost of RIZIV
Other reasons (demography)
Why medicines bring the system in danger? (1)
High pricesHigher then the neighbouring
countries (France, Netherlands)• Zocor (cholesterol-lowering drugs: 26 and
35% higher) • NGO Orbi-Pharma: 15 tot 60 times
cheaper
Why medicines bring the system in danger? (2)
Low quality: most expensive medicines are not those scientifically proven to have the most benefit
Top 5 of the most expensive medicines for RIZIV (2002)
Name Therapeutic class Producer Net cost (in millionEuro)
1.Lipitor Cholesterol lowering drug Pfizer 70.9
2.Zocor Cholesterol loweringdrug
Merck Sharp&Dohme 44.4
3.Amlor Anti-hypertensivedrug
Pfizer 34.5
4.Cipramil Anti-depressant Lundbeck 33.2
5.Pravasine Cholesterol loweringdrug
Birstol-Meyers Squibb 26.8
Why medicines bring the system in danger? (3)
Imitations and “me toos”Most of the research is not to search
for new medicines, but to make imitations and adjustments of the product
To obtain admission of a new product: new medicine has an effect or it should be better than placebo and it’s safe
Why medicines bring the system in danger? (4)
“New” product: Lucentis (2.000 dollar)Same active component as Avantis
(cancer): 20 dollar Study of National Institute for Health
Care Management (NIHCM):153 or 15% of all 1.035 medicines,
admitted for sell by the American Food & Drug Administration (FDA) had more therapeutic value
Why medicines bring the system in danger? (5)
Irrational use of medicines and marketingDirect to consumer advertising for
medicines without prescription is legal• Producers of Neurofen, Alevem Daflon
and Venoruton are making super profits, but have no proven beneficial effect
Why medicines bring the system in danger? (6)
Valuable and life-saving medicines are withdraw from market when they become too cheap and more expensive alternatives are available (Furadantine, Penidur)
Doctors are object of publicity because they lack necessary information (pharmaceutical industry: 1 billion dollar or 1.000 times the amount for independent education)
A rational drug policy exists(1)
Based on the health system in New Zealand: kiwi-model (Pharmac: quality, effectiveness and price)
The new institute aims to realize The most efficient and accessible
health policyHighest health protection at the lowest
price
A rational drug policy exists(2)
Strategy of the new institute:Independent team of expertsScientific demand-driven analysesObjective, scientific criteria and
studiesPublic bidding or cross dealsReimbursed if it has a clear
therapeutic surplus value
Challenges (1)
implementation of the kiwi-model without vitamins (protest of pharm. industry, politicians and doctors)public bidding only for products
without patent (cholesterol-lowering drugs)
Compensation for products that don’t win, but patients pay more
Firms get reduction if they use less marketing and publicity
Challenges (2)
More and more coercive directives of the European Commission, where health a part is of the sector entreprisesTRIPS: prices rose with 12 to 200%Availability of cheaper generic
medicines slow down97 of patents are registered in rich
countries
Challenges (3)
Nationalization of the pharmaceutical industry is needed, but a national drugs policy on public tender as the kiwi-model would be a valuable step